The cluster is small relative to market cap and largely tied to option exercises, making it a routine diversification event rather than a bearish signal. Monitor for any material news (pipeline updates, regulatory filings) that could explain the timing, but no immediate trading action is warranted based on this cluster alone.
PHVS drugs
PHVS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 27 $29.47entry
- T+1 · 6mo ago +1.32%α +0.77% · $29.86
- T+5 · 6mo ago +2.27%α +1.80% · $30.14
- T+20 · 5mo ago +13.00%α +14.90% · $33.30
- T+60 · 3mo ago +23.48%α +21.60% · $36.39
Price Chart
How similar events traded
Executive Summary
A cluster of 8 Pharvaris insiders, including the CEO, CFO, and CCO, sold a total of $1.73M in open-market sales over a 7-day window. While the dollar amount is modest relative to the $2.1B market cap (~0.08%), the breadth of C-suite participation and the absence of any open-market buying is notable. The sales follow option exercises and coincide with the stock trading near recent highs, suggesting routine portfolio diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- 8 insiders sold a total of $1.73M in open-market sales over 7 days (May 14-21, 2026)
- CFO David Nassif sold $303K, CEO Berndt Modig sold $67K, CCO Wim Souverijns sold $299K
- Total sales represent ~0.08% of Pharvaris' $2.1B market cap, below the 0.1% materiality threshold
- Several sales were preceded by option exercises at $0 or $8.05 strike prices, indicating tax-motivated selling
- No open-market purchases were reported in the cluster window
- The stock has a 90% bullish analyst consensus and recent insider activity (30d) totaled $1.1M in sales
Financial Impact
Total insider sales of $1.73M, or ~0.08% of market cap
Risk Factors
- Insider sales could accelerate if the stock continues to rally, creating overhang
- Lack of insider buying at current levels may indicate management sees limited near-term upside
- Biotech sector volatility could amplify any negative read-through from insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1779832444919 |
Track record
51 reports on PHVS
15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
- Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Nov 12, 20264d ago 6-K Neutral 4/10 No price data
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
- Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers